These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178 [No Abstract] [Full Text] [Related]
5. Vaccination against hepatitis B and C: towards therapeutic application. Inchauspe G; Bach G; Martin P; Bonnefoy JY Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251 [No Abstract] [Full Text] [Related]
6. Therapeutic vaccination for hepatitis C: can protective T-cell responses be restored after prolonged antigen exposure? Ferrari C Gastroenterology; 2008 May; 134(5):1601-4. PubMed ID: 18471527 [No Abstract] [Full Text] [Related]
7. European guideline for the management of hepatitis B and C virus infections. Brook MG; Int J STD AIDS; 2001 Oct; 12 Suppl 3():48-57. PubMed ID: 11589797 [No Abstract] [Full Text] [Related]
8. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. Torresi J; Johnson D; Wedemeyer H J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C vaccine approaches phase II trial. McNeil C J Natl Cancer Inst; 2006 Mar; 98(5):301-2. PubMed ID: 16507825 [No Abstract] [Full Text] [Related]
10. American Association for the Study of Liver Diseases (AASLD)--56th Annual Meeting. Phend C IDrugs; 2006 Feb; 9(2):96-100. PubMed ID: 16523396 [No Abstract] [Full Text] [Related]
11. [Immunoprophylaxis of viral hepatitis]. Biesiada G; Mach T Przegl Lek; 2003; 60(9):598-601. PubMed ID: 15065341 [TBL] [Abstract][Full Text] [Related]
13. What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States? Buckley GJ; Strom BL Ann Intern Med; 2016 Aug; 165(4):284-5. PubMed ID: 27064885 [No Abstract] [Full Text] [Related]
14. Infectious diseases. Hard-won advances spark excitement about hepatitis C. Crabb C Science; 2001 Oct; 294(5542):506-7. PubMed ID: 11641482 [No Abstract] [Full Text] [Related]
15. Statement on hepatitis vaccines for travellers. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT) Can Commun Dis Rep; 2008 Jul; 34(ACS-2):1-24. PubMed ID: 18802989 [No Abstract] [Full Text] [Related]